Characterization and modulation of the transferrin receptor on brain capillary endothelial cells

Pharm Res. 2004 May;21(5):761-9. doi: 10.1023/b:pham.0000026425.69874.8e.

Abstract

Purpose: The expression level of the transferrin receptor (TfR) on brain capillary endothelial cells (BCECs) and the endocytosis of 125I-transferrin (125I-Tf) by this receptor was investigated. Furthermore, the influence of iron, the iron scavenger deferoxamine mesylate (DFO), astrocytic factors, a GTP-ase inhibitor (tyrphostin-A8, T8), lipopolysaccharide (LPS), and the radical scavenger N-acetyl-L-cysteine (NAC) on the TfR expression was studied to gain insight in the use and optimization of the TfR for drug targeting to the brain.

Methods: Experiments were performed with primary cultured bovine BCECs that were incubated with 125I-Tf at 4 degrees C (to determine binding) or at 37 degrees C (to determine endocytosis) in the absence or presence of the modulators. For full saturation curves in the absence or presence of iron or DFO, analysis was performed with a population approach using NONMEM, allowing us to estimate a single value for affinity (Kd, concentration of 50% receptor occupancy) and separate values for maximum receptor occupancy (B(max).

Results: On BCECs, the TfR is expressed extracellularly (B(max) of 0.13 fmol/microg cell protein), but also has a large intracellular pool (total B(max) of 1.37 fmol/microg cell protein), and is actively endocytosing Tf via clathrin-coated vesicles. At 4 degrees C, a Kd of 2.38 microg/ml was found, whereas the Kd at 37 degrees C was 5.03 microg/ml. Furthermore, DFO is able to increase both the extracellular as well as the total binding capacity to 0.63 and 3.67 fmol/microg cell protein, respectively, whereas it had no influence on Kd. B(max) at 37 degrees C after DFO preincubation was also increased from 0.90 to 2.31 fmol/microg cell protein. Other modulators had no significant influence on the TfR expression levels, though LPS increased cellular protein concentrations after 2-h preincubation.

Conclusions: The TfR is expressed on BCECs and actively endocytoses Tf, making it a suitable target for drug delivery to the bloodbrain barrier and the CNS. DFO up-regulates the TfR expression level, which may influence targeting efficiency.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology
  • Animals
  • Astrocytes / metabolism
  • Astrocytes / physiology
  • Capillaries / metabolism
  • Cattle
  • Cells, Cultured
  • Cerebrovascular Circulation / physiology*
  • Deferoxamine / pharmacology
  • Down-Regulation
  • Endocytosis / drug effects
  • Endocytosis / physiology
  • Endothelial Cells / metabolism*
  • Extracellular Space / metabolism
  • Free Radical Scavengers / pharmacology
  • Inflammation / metabolism
  • Iron / pharmacology
  • Lipopolysaccharides / pharmacology
  • Receptors, Transferrin / metabolism*
  • Transferrin / metabolism
  • Tyrphostins / pharmacology

Substances

  • Free Radical Scavengers
  • Lipopolysaccharides
  • Receptors, Transferrin
  • Transferrin
  • Tyrphostins
  • tyrphostin 8
  • Iron
  • Deferoxamine
  • Acetylcysteine